Viewing Study NCT02705859


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT02705859
Status: COMPLETED
Last Update Posted: 2025-01-09
First Post: 2016-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)
Sponsor: Cancer Trials Ireland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Positive Breast Cancer View
Keywords: